Skip to content
1887

Abstract

Equine arteritis virus (EAV) is the causative agent of equine viral arteritis, a notifiable respiratory and reproductive disease of equids that causes significant losses to the equine industry. This study presents a comprehensive analysis of two EAV outbreaks in the UK in 2019, combining virus isolation, sequencing and phylogenetic analysis to provide a holistic understanding of EAV dynamics in these outbreaks. Genetic characterization revealed that all outbreak strains were similar to viruses detected in the UK and Europe from 2004 to 2011, belonging to phylogroup D and clustering in two groups as expected based on epidemiological profiling. Bayesian phylogenetic analysis indicated the direction of transmission. The 2019 EAV strains showed maximum variability in glycoprotein (GP) 3, followed by GP2, non-structural protein 2, GP4 and GP5, with one strain displaying a unique truncation in GP4 at position 149, a feature not previously identified in arteriviruses. Polymorphisms in the CXCL16 gene have been implicated in differential susceptibility to the establishment of long-term carrier states of EAV in stallions. Genotypic analysis of the CXCL16 gene revealed that one horse possessed the homozygous genotype associated with resistance to persistent infection. In contrast, the remaining four horses exhibited the heterozygous genotype, which has been linked to an increased risk of developing a long-term carrier state and contributing to ongoing viral transmission. All infected horses exhibited the presence of neutralizing antibodies in their serum. This study underscores the importance of early detection of silent infections to reduce the spread and prevent clinical outbreaks.

Funding
This study was supported by the:
  • DEFRA (Award EXSV3300)
    • Principal Award Recipient: FalkoSteinbach
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.002181
2025-12-03
2025-12-16

Metrics

Loading full text...

Full text loading...

/deliver/fulltext/jgv/106/12/jgv002181.html?itemId=/content/journal/jgv/10.1099/jgv.0.002181&mimeType=html&fmt=ahah

References

  1. OIE OIE terrestrial manual, Chapter 3.5.10. - Equine viral arteritis (infection with equine arteritis virus); 2018 https://www.woah.org/fileadmin/Home/eng/Health_standards/tahm/3.05.10_EVA.pdf accessed 5 June 2023
  2. ICTV Family: Arteriviridae Chapter Version: ICTV Ninth Report; 2009 Taxonomy Release; 2011 https://ictv.global/report_9th/RNApos/Nidovirales/Arteriviridae accessed 12 January 2024
  3. Snijder EJ, Kikkert M, Fang Y. Arterivirus molecular biology and pathogenesis. J Gen Virol 2013; 94:2141–2163 [View Article]
    [Google Scholar]
  4. Timoney PJ, McCollum WH, Roberts AW, Murphy TW. Demonstration of the carrier state in naturally acquired equine arteritis virus infection in the stallion. Res Vet Sci 1986; 41:279–280 [View Article] [PubMed]
    [Google Scholar]
  5. Timoney PJ, McCollum WH. Equine viral arteritis. Vet Clin North Am Equine Pract 1993; 9:295–309 [View Article] [PubMed]
    [Google Scholar]
  6. Carossino M, Dini P, Kalbfleisch TS, Loynachan AT, Canisso IF et al. Equine arteritis virus long-term persistence is orchestrated by CD8+ T lymphocyte transcription factors, inhibitory receptors, and the CXCL16/CXCR6 axis. PLoS Pathog 2019; 15:e1007950 [View Article] [PubMed]
    [Google Scholar]
  7. Balasuriya UBR, Hedges JF, Smalley VL, Navarrette A, McCollum WH et al. Genetic characterization of equine arteritis virus during persistent infection of stallions. J Gen Virol 2004; 85:379–390 [View Article] [PubMed]
    [Google Scholar]
  8. Miszczak F, Legrand L, Balasuriya UBR, Ferry-Abitbol B, Zhang J et al. Emergence of novel equine arteritis virus (EAV) variants during persistent infection in the stallion: origin of the 2007 French EAV outbreak was linked to an EAV strain present in the semen of a persistently infected carrier stallion. Virology 2012; 423:165–174 [View Article] [PubMed]
    [Google Scholar]
  9. Balasuriya UBR, Carossino M, Timoney PJ. Equine viral arteritis: a respiratory and reproductive disease of significant economic importance to the equine industry. Equ Vet Ed 2018; 30:497–512 [View Article]
    [Google Scholar]
  10. HBLB International codes of practice 2023 – equine viral arteritis; 2023 https://codes.hblb.org.uk/index.php/page/30 accessed 15 November 2023
  11. Bryans JT, Crowe ME, Doll ER, McCollum WH. Isolation of a filterable agent causing arteritis of horses and abortion by mares; its differentiation from the equine abortion (influenza) virus. Cornell Vet 1957; 47:3–41 [PubMed]
    [Google Scholar]
  12. Laabassi F, Amelot G, Laugier C, Zientara S, Nasri AM et al. Prevalence of equine viral arteritis in Algeria. Rev Sci Tech 2014; 33:967–974 [View Article] [PubMed]
    [Google Scholar]
  13. Otzdorff C, Beckmann J, Goehring LS. Equine Arteritis Virus (EAV) outbreak in a show stallion population. Viruses 2021; 13:2142 [View Article] [PubMed]
    [Google Scholar]
  14. Gaudaire D, Lazić S, Lupulović D, Petrovic T, Lazić G et al. Complete genome sequence of an equine arteritis virus strain isolated from a Lipizzaner stallion in 2015 in Serbia. Microbiol Resour Announc 2019; 8:e00250-19 [View Article] [PubMed]
    [Google Scholar]
  15. Rivas J, Neira V, Mena J, Brito B, Garcia A et al. Identification of a divergent genotype of equine arteritis virus from South American donkeys. Transbound Emerg Dis 2017; 64:1655–1660 [View Article] [PubMed]
    [Google Scholar]
  16. Cruz F, Fores P, Mughini-Gras L, Ireland J, Moreno MA et al. Seroprevalence and factors associated with seropositivity to equine arteritis virus in Spanish Purebred horses in Spain. Equine Vet J 2016; 48:573–577 [View Article] [PubMed]
    [Google Scholar]
  17. Lazić S, Lupulović D, Gaudaire D, Petrovic T, Lazić G et al. Serological evidence of equine arteritis virus infection and phylogenetic analysis of viral isolates in semen of stallions from Serbia. BMC Vet Res 2017; 13:316 [View Article] [PubMed]
    [Google Scholar]
  18. Amat JP, Vergne T, Tapprest J, Ferry B, Hans A et al. Estimating the incidence of equine viral arteritis and the sensitivity of its surveillance in the French breeding stock. Vet Microbiol 2016; 192:34–42 [View Article] [PubMed]
    [Google Scholar]
  19. Jiménez D, Romero-Zuñiga JJ, Dolz G. Serosurveillance of infectious agents in equines of the Central Valley of Costa Rica. Open Vet J 2014; 4:107–112 [View Article] [PubMed]
    [Google Scholar]
  20. Wood JL, Chirnside ED, Mumford JA, Higgins AJ. First recorded outbreak of equine viral arteritis in the United Kingdom. Vet Rec 1995; 136:381–385 [View Article] [PubMed]
    [Google Scholar]
  21. The equine viral arteritis order; 1995 https://www.legislation.gov.uk/uksi/1995/1755/contents/made accessed 15 November 2023
  22. Newton JR, Wood JL, Castillo-Olivares FJ, Mumford JA. Serological surveillance of equine viral arteritis in the United Kingdom since the outbreak in 1993. Vet Rec 1999; 145:511–516 [View Article] [PubMed]
    [Google Scholar]
  23. Manser P, Westcott D. Equine viral arteritis in a stallion. Vet Rec 2005; 156:28 [PubMed]
    [Google Scholar]
  24. Crabtree JR, Newton JR. Equine viral arteritis (EVA): a potential trapdoor for the practicing veterinary surgeon in the United Kingdom. Equ Vet Ed 2020; 32:378–385 [View Article]
    [Google Scholar]
  25. Steinbach F, Westcott DG, McGowan SL, Grierson SS, Frossard JP et al. Re-emergence of a genetic outlier strain of equine arteritis virus: impact on phylogeny. Virus Res 2015; 202:144–150 [View Article] [PubMed]
    [Google Scholar]
  26. APHA Equine viral arteritis: epidemiology reports; 2019 https://www.gov.uk/government/publications/epidemiology-report-eva-virus-2019 accessed 15 November 2023
  27. Lattimer J, Roberts H, Barnard M, Paterson A, Bell I et al. Investigating an outbreak of equine viral arteritis at two connected premises. Vet Rec 2020; 187:e113 [View Article] [PubMed]
    [Google Scholar]
  28. APHA Epidemiology report detailing the investigation of EVA virus disclosed on a premises in Shropshire; 2019 https://www.gov.uk/government/publications/epidemiology-report-eva-virus-2019/epidemiology-report-detailing-the-investigation-of-eva-virus-disclosed-on-a-premises-in-shropshire-july-2019 accessed 20 November 2023
  29. Stadejek T, Bj Rklund H, Bascu Ana CR, Ciabatti IM, Scicluna MT et al. Genetic diversity of equine arteritis virus. J Gen Virol 1999; 80 (Pt 3):691–699 [View Article] [PubMed]
    [Google Scholar]
  30. Balasuriya UBR, Leutenegger CM, Topol JB, McCollum WH, Timoney PJ et al. Detection of equine arteritis virus by real-time TaqMan reverse transcription-PCR assay. J Virol Methods 2002; 101:21–28 [View Article] [PubMed]
    [Google Scholar]
  31. Toussaint JF, Sailleau C, Breard E, Zientara S, De Clercq K. Bluetongue virus detection by two real-time RT-qPCRs targeting two different genomic segments. J Virol Methods 2007; 140:115–123 [View Article] [PubMed]
    [Google Scholar]
  32. Kumar S, Stecher G, Li M, Knyaz C, Tamura K. MEGA X: molecular evolutionary genetics analysis across computing platforms. Mol Biol Evol 2018; 35:1547–1549 [View Article] [PubMed]
    [Google Scholar]
  33. Pavlidis P, Noble WS. Matrix2png: a utility for visualizing matrix data. Bioinformatics 2003; 19:295–296 [View Article] [PubMed]
    [Google Scholar]
  34. Ronquist F, Teslenko M, van der Mark P, Ayres DL, Darling A et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol 2012; 61:539–542 [View Article] [PubMed]
    [Google Scholar]
  35. Letunic I, Bork P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 2021; 49:W293–W296 [View Article] [PubMed]
    [Google Scholar]
  36. Huelsenbeck JP, Ronquist F, Nielsen R, Bollback JP. Bayesian inference of phylogeny and its impact on evolutionary biology. Science 2001; 294:2310–2314 [View Article] [PubMed]
    [Google Scholar]
  37. Huelsenbeck JP, Ronquist F. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 2001; 17:754–755 [View Article] [PubMed]
    [Google Scholar]
  38. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints12. Am J Hyg 1938; 27:493–497 [View Article]
    [Google Scholar]
  39. NetNGlyc 1.0 N-linked glycosylation sites in human proteins; 2023 https://services.healthtech.dtu.dk/services/NetNGlyc-1.0/ accessed 13 November 2023
  40. Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res 2004; 14:1188–1190 [View Article] [PubMed]
    [Google Scholar]
  41. Kosakovsky Pond SL, Frost SDW. Not so different after all: a comparison of methods for detecting amino acid sites under selection. Mol Biol Evol 2005; 22:1208–1222 [View Article] [PubMed]
    [Google Scholar]
  42. Murrell B, Wertheim JO, Moola S, Weighill T, Scheffler K et al. Detecting individual sites subject to episodic diversifying selection. PLoS Genet 2012; 8:e1002764 [View Article] [PubMed]
    [Google Scholar]
  43. Murrell B, Moola S, Mabona A, Weighill T, Sheward D et al. FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol 2013; 30:1196–1205 [View Article] [PubMed]
    [Google Scholar]
  44. Sarkar S, Bailey E, Go YY, Cook RF, Kalbfleisch T et al. Allelic variation in CXCL16 determines CD3+ T lymphocyte susceptibility to equine arteritis virus infection and establishment of long-term carrier state in the stallion. PLoS Genet 2016; 12:e1006467 [View Article] [PubMed]
    [Google Scholar]
  45. Rola J, Larska M, Rola JG, Belák S, Autorino GL. Epizotiology and phylogeny of equine arteritis virus in hucul horses. Vet Microbiol 2011; 148:402–407 [View Article] [PubMed]
    [Google Scholar]
  46. Balasuriya UBR, Dobbe JC, Heidner HW, Smalley VL, Navarrette A et al. Characterization of the neutralization determinants of equine arteritis virus using recombinant chimeric viruses and site-specific mutagenesis of an infectious cDNA clone. Virology 2004; 321:235–246 [View Article] [PubMed]
    [Google Scholar]
  47. Balasuriya UBR, Patton JF, Rossitto PV, Timoney PJ, McCollum WH et al. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the GL envelope glycoprotein. Virology 1997; 232:114–128 [View Article]
    [Google Scholar]
  48. Balasuriya UB, Timoney PJ, McCollum WH, MacLachlan NJ. Phylogenetic analysis of open reading frame 5 of field isolates of equine arteritis virus and identification of conserved and nonconserved regions in the GL envelope glycoprotein. Virology 1995; 214:690–697 [View Article] [PubMed]
    [Google Scholar]
  49. Metz GE, Ocampos GPM, Serena MS, Gambaro SE, Nosetto E et al. Extended phylogeny of the equine arteritis virus sequences including South American sequences. Intervirology 2011; 54:30–36 [View Article] [PubMed]
    [Google Scholar]
  50. Hedges JF, Balasuriya UB, Topol JB, Lee DW, MacLachlan NJ. Genetic variation of ORFs 3 and 4 of equine arteritis virus. Adv Exp Med Biol 2001; 494:69–72 [View Article] [PubMed]
    [Google Scholar]
  51. Lauck M, Alkhovsky SV, Bào Y, Bailey AL, Shevtsova ZV et al. Historical outbreaks of simian hemorrhagic fever in captive macaques were caused by distinct arteriviruses. J Virol 2015; 89:8082–8087 [View Article]
    [Google Scholar]
  52. Oğuzoğlu , Karapınar Z, Bilge-Dagalp S. Partial sequence of the orf1b gene fragment of equine arteritis viruses detected in turkey and phylogenic analysis. Revue de Medecine Veterinaire 2013
    [Google Scholar]
  53. Mittelholzer C, Stadejek T, Johansson I, Baule C, Ciabatti I et al. Extended phylogeny of equine arteritis virus: division into new subgroups. J Vet Med B Infect Dis Vet Public Health 2006; 53:55–58 [View Article] [PubMed]
    [Google Scholar]
  54. Vanmechelen B, Vergote V, Laenen L, Koundouno FR, Bore JA et al. Expanding the arterivirus host spectrum: Olivier’s shrew virus 1, a novel arterivirus discovered in African giant shrews. Sci Rep 2018; 8:11171 [View Article]
    [Google Scholar]
  55. Snijder EJ, Meulenberg JJ. The molecular biology of arteriviruses. J Gen Virol 1998; 79 (Pt 5):961–979 [View Article] [PubMed]
    [Google Scholar]
  56. Dortmans JCFM, Buter GJ, Dijkman R, Houben M, Duinhof TF. Molecular characterization of type 1 porcine reproductive and respiratory syndrome viruses (PRRSV) isolated in the Netherlands from 2014 to 2016. PLoS One 2019; 14:e0218481 [View Article] [PubMed]
    [Google Scholar]
  57. Kvisgaard LK, Hjulsager CK, Kristensen CS, Lauritsen KT, Larsen LE. Genetic and antigenic characterization of complete genomes of type 1 Porcine Reproductive and Respiratory Syndrome viruses (PRRSV) isolated in Denmark over a period of 10 years. Virus Res 2013; 178:197–205 [View Article] [PubMed]
    [Google Scholar]
  58. Hedges JF, Balasuriya UB, Timoney PJ, McCollum WH, MacLachlan NJ. Genetic divergence with emergence of novel phenotypic variants of equine arteritis virus during persistent infection of stallions. J Virol 1999; 73:3672–3681 [View Article] [PubMed]
    [Google Scholar]
  59. Vigerust DJ, Shepherd VL. Virus glycosylation: role in virulence and immune interactions. Trends Microbiol 2007; 15:211–218 [View Article] [PubMed]
    [Google Scholar]
  60. Feng T, Zhang J, Chen Z, Pan W, Chen Z et al. Glycosylation of viral proteins: implication in virus–host interaction and virulence. Virulence 2022; 13:670–683 [View Article]
    [Google Scholar]
  61. Balasuriya UB, Patton JF, Rossitto PV, Timoney PJ, McCollum WH et al. Neutralization determinants of laboratory strains and field isolates of equine arteritis virus: identification of four neutralization sites in the amino-terminal ectodomain of the G(L) envelope glycoprotein. Virology 1997; 232:114–128 [View Article] [PubMed]
    [Google Scholar]
  62. Wagner HM, Balasuriya UBR, James MacLachlan N. The serologic response of horses to equine arteritis virus as determined by competitive enzyme-linked immunosorbent assays (c-ELISAs) to structural and non-structural viral proteins. Comp Immunol Microbiol Infect Dis 2003; 26:251–260 [View Article] [PubMed]
    [Google Scholar]
/content/journal/jgv/10.1099/jgv.0.002181
Loading
/content/journal/jgv/10.1099/jgv.0.002181
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error